Table 1 Body weight and lipid levels in 8 months old non-diabetic Wistar (W) and diabetic Goto-Kakizaki (GK) rats and in GK rats treated with sulforaphane (GKS), pyridoxamine (GKP) or sulforaphane and pyridoxamine (GKSP).

From: The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes

 

W

GK

GKS

GKP

GKSP

Body weight (g)

478.5 ± 15.2

390 ± 5.7***

374.6 ± 5.3***

401.8 ± 6.6***

375 ± 9.3***

Total Cholesterol (mM)

2.07 ± 0.07

2.75 ± 0.07**

2.74 ± 0.14

2.53 ± 0.16***

2.71 ± 0.14 **

Non-HDL cholesterol (mM)

0.87 ± 0.04

1.1 ± 0.06

1.02 ± 0.09

0.086 ± 0.08

1.14 ± 0.08

Triglycerides (mM)

0.94 ± 0.07

1.18 ± 0.1

1.04 ± 1.0

1.29 ± 0.07

1.11 ± 0.06

FFA (mM)

0.58 ± 0.02

1.21 ± 0.08***

0.97 ± 0.06 **

0.99 ± 0.13*

0.73 ± 0.06ϕϕϕ,§,#

  1. Data are expressed as mean±SE (n = 12 animals in each group).
  2. *P < 0.05, **P < 0.01, ***P < 0.001 vs W rats.
  3. ϕϕϕP < 0.001 vs GK rats.
  4. §P < 0.05 vs GKS rats.
  5. #P < 0.05 vs GKP.
Back to article page